234 related articles for article (PubMed ID: 26441135)
1. Towards a blood-based diagnostic panel for bipolar disorder.
Haenisch F; Cooper JD; Reif A; Kittel-Schneider S; Steiner J; Leweke FM; Rothermundt M; van Beveren NJM; Crespo-Facorro B; Niebuhr DW; Cowan DN; Weber NS; Yolken RH; Penninx BWJH; Bahn S
Brain Behav Immun; 2016 Feb; 52():49-57. PubMed ID: 26441135
[TBL] [Abstract][Full Text] [Related]
2. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein: A differential biomarker for major depressive disorder and bipolar II disorder.
Chang HH; Wang TY; Lee IH; Lee SY; Chen KC; Huang SY; Yang YK; Lu RB; Chen PS
World J Biol Psychiatry; 2017 Feb; 18(1):63-70. PubMed ID: 26895280
[TBL] [Abstract][Full Text] [Related]
4. AI algorithm combined with RNA editing-based blood biomarkers to discriminate bipolar from major depressive disorders in an external validation multicentric cohort.
Salvetat N; Checa-Robles FJ; Delacrétaz A; Cayzac C; Dubuc B; Vetter D; Dainat J; Lang JP; Gamma F; Weissmann D
J Affect Disord; 2024 Jul; 356():385-393. PubMed ID: 38615844
[TBL] [Abstract][Full Text] [Related]
5. Profiling of the Peripheral Blood Mononuclear Cell Proteome in Schizophrenia and Mood Disorders for the Discovery of Discriminatory Biomarkers: A Proof-of-Concept Study.
Coppens V; De Wachter O; Goossens J; Hendrix J; Maudsley S; Azmi A; van Gastel J; Van Saet A; Lauwers T; Morrens M
Neuropsychobiology; 2020; 79(4-5):324-334. PubMed ID: 32392557
[TBL] [Abstract][Full Text] [Related]
6. Differentiation between major depressive disorder and bipolar disorder by auditory steady-state responses.
Isomura S; Onitsuka T; Tsuchimoto R; Nakamura I; Hirano S; Oda Y; Oribe N; Hirano Y; Ueno T; Kanba S
J Affect Disord; 2016 Jan; 190():800-806. PubMed ID: 26625092
[TBL] [Abstract][Full Text] [Related]
7. Metabolomic Biomarker Signatures for Bipolar and Unipolar Depression.
Tomasik J; Harrison SJ; Rustogi N; Olmert T; Barton-Owen G; Han SYS; Cooper JD; Eljasz P; Farrag LP; Friend LV; Bell E; Cowell D; Bahn S
JAMA Psychiatry; 2024 Jan; 81(1):101-106. PubMed ID: 37878349
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study.
Pan JX; Xia JJ; Deng FL; Liang WW; Wu J; Yin BM; Dong MX; Chen JJ; Ye F; Wang HY; Zheng P; Xie P
Transl Psychiatry; 2018 Jul; 8(1):130. PubMed ID: 29991685
[TBL] [Abstract][Full Text] [Related]
9. Assessment of a multi-assay biological diagnostic test for mood disorders in a Japanese population.
Yamamori H; Ishima T; Yasuda Y; Fujimoto M; Kudo N; Ohi K; Hashimoto K; Takeda M; Hashimoto R
Neurosci Lett; 2016 Jan; 612():167-171. PubMed ID: 26687272
[TBL] [Abstract][Full Text] [Related]
10. Higher serum VGF protein levels discriminate bipolar depression from major depressive disorder.
Chen S; Jiang H; Hou Z; Yue Y; Zhang Y; Zhao F; Xu Z; Li Y; Mou X; Li L; Wang T; Zhao J; Han C; Sui Y; Wang M; Yang Z; Lu Y; Zhu Y; Li J; Shen X; Sun F; Chen Q; Yuan Y
J Neurosci Res; 2019 May; 97(5):597-606. PubMed ID: 30575991
[TBL] [Abstract][Full Text] [Related]
11. Identification of an Immune-Neuroendocrine Biomarker Panel for Detection of Depression: A Joint Effects Statistical Approach.
Chan MK; Cooper JD; Bot M; Steiner J; Penninx BW; Bahn S
Neuroendocrinology; 2016; 103(6):693-710. PubMed ID: 26580065
[TBL] [Abstract][Full Text] [Related]
12. Sociodemographic and clinical features of bipolar disorder patients misdiagnosed with major depressive disorder in China.
Xiang YT; Zhang L; Wang G; Hu C; Ungvari GS; Dickerson FB; Kilbourne AM; Si TM; Fang YR; Lu Z; Yang HC; Lai KY; Lee EH; Hu J; Chen ZY; Huang Y; Sun J; Wang XP; Li HC; Zhang JB; Chiu HF
Bipolar Disord; 2013 Mar; 15(2):199-205. PubMed ID: 23437963
[TBL] [Abstract][Full Text] [Related]
13. Identification of plasma biomarkers for distinguishing bipolar depression from major depressive disorder by iTRAQ-coupled LC-MS/MS and bioinformatics analysis.
Ren J; Zhao G; Sun X; Liu H; Jiang P; Chen J; Wu Z; Peng D; Fang Y; Zhang C
Psychoneuroendocrinology; 2017 Dec; 86():17-24. PubMed ID: 28910601
[TBL] [Abstract][Full Text] [Related]
14. Platelet-derived growth factor BB: A potential diagnostic blood biomarker for differentiating bipolar disorder from major depressive disorder.
Idemoto K; Ishima T; Niitsu T; Hata T; Yoshida S; Hattori K; Horai T; Otsuka I; Yamamori H; Toda S; Kameno Y; Ota K; Oda Y; Kimura A; Hashimoto T; Mori N; Kikuchi M; Minabe Y; Hashimoto R; Hishimoto A; Nakagome K; Iyo M; Hashimoto K
J Psychiatr Res; 2021 Feb; 134():48-56. PubMed ID: 33360224
[TBL] [Abstract][Full Text] [Related]
15. Explainable machine-learning algorithms to differentiate bipolar disorder from major depressive disorder using self-reported symptoms, vital signs, and blood-based markers.
Zhu T; Liu X; Wang J; Kou R; Hu Y; Yuan M; Yuan C; Luo L; Zhang W
Comput Methods Programs Biomed; 2023 Oct; 240():107723. PubMed ID: 37480646
[TBL] [Abstract][Full Text] [Related]
16. Search for plasma biomarkers in drug-free patients with bipolar disorder and schizophrenia using metabolome analysis.
Kageyama Y; Kasahara T; Morishita H; Mataga N; Deguchi Y; Tani M; Kuroda K; Hattori K; Yoshida S; Inoue K; Kato T
Psychiatry Clin Neurosci; 2017 Feb; 71(2):115-123. PubMed ID: 27676126
[TBL] [Abstract][Full Text] [Related]
17. A machine learning algorithm to differentiate bipolar disorder from major depressive disorder using an online mental health questionnaire and blood biomarker data.
Tomasik J; Han SYS; Barton-Owen G; Mirea DM; Martin-Key NA; Rustogi N; Lago SG; Olmert T; Cooper JD; Ozcan S; Eljasz P; Thomas G; Tuytten R; Metcalfe T; Schei TS; Farrag LP; Friend LV; Bell E; Cowell D; Bahn S
Transl Psychiatry; 2021 Jan; 11(1):41. PubMed ID: 33436544
[TBL] [Abstract][Full Text] [Related]
18. Functional versus syndromal recovery in patients with major depressive disorder and bipolar disorder.
van der Voort TY; Seldenrijk A; van Meijel B; Goossens PJ; Beekman AT; Penninx BW; Kupka RW
J Clin Psychiatry; 2015 Jun; 76(6):e809-14. PubMed ID: 26132690
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of metabolomics-based urinary biomarker models for recognizing major depression disorder and bipolar disorder.
Wang T; Yang J; Zhu Y; Niu N; Ding B; Wang P; Zhao H; Li N; Chao Y; Gao S; Dong X; Wang Z
J Affect Disord; 2024 Jul; 356():1-12. PubMed ID: 38548210
[TBL] [Abstract][Full Text] [Related]
20. Metabolomics of Major Depressive Disorder and Bipolar Disorder: Overview and Future Perspective.
Hashimoto K
Adv Clin Chem; 2018; 84():81-99. PubMed ID: 29478517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
